Here are six recent news updates on GI/endoscopy companies.
The European Commission granted approval for AbbVie's all-pill hepatitis C treatment for use in the 28 European Union countries, according to an abc News report.
Michael Phalen, executive vice president with Boston Scientific, sold 10,000 shares of company stock for a total transaction value of $145,400, according to a WKRB News & Analysis report.
Non-profit association Georgia Bio granted EndoChoice one of its Innovation Awards for the Fuse Full Spectrum Endoscopy System.
India's patent office rejected Gilead Science's key patent claim for its hepatitis C drug Sovaldi. Gilead Sciences has the option to appeal the rejection.
Medigus extended its 2013 exclusive distribution agreement with Chinese pharmaceutical company Sinopharm. The agreement grants Sinopharm exclusive rights to distribute the MUSE system in China.
Salix Pharmaceuticals is working with investment bank Centerview Partners Holdings to explore options, such as a potential sale, according to a Reuters report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.